Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Score changes after a secured card usually appear over weeks to months, driven by utilization and payment history. Here’s how to gauge progress.
25,688 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Big tech’s heavy AI investments are pinching buyback payouts, reshaping capital allocation as investors weigh dividen...
At a Miami conference this week, Tom Lee floated a $22,000 Ethereum target, tying it to a mix of Bitcoin price milest...
New risk signals emerge as the S&P 500 grows more concentrated. Top 10 names and chipmakers now drive most of the mar...
As AI data centers expand, three optics names have led the charge in 2026. Through May, AAOI has surged, while LITE a...
Three under-$10 energy names are drawing attention as one yields 8.8%, another is up 83% in a year, and market chatte...
As data suggests inflation remains stubborn and yields stay elevated, investors confront the reality that trump wants...
Ford stock keeps going as investors bet on EV momentum and steady cash flow. This guide breaks down the factors fueli...
Inflation soaring again, this under-the-radar ETF is quietly drawing interest from investors seeking an edge against ...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
The musician sheryl crow selling a 2.2-acre slice from her Nashville estate for $1.8 million highlights growing liqui...
Bitmine’s Ethereum hoard surges to 5.28 million ETH, placing the treasury near a 5% stake of total supply as the comp...